LegoChem Biosciences, Inc. (141080.KQ)

KRW 96700.0

(-6.84%)

Net Debt Summary of LegoChem Biosciences, Inc.

LegoChem Biosciences, Inc.'s latest annual net debt in 2023 was -56.05 Billion KRW , up 46.98% from previous year.
LegoChem Biosciences, Inc.'s latest quarterly net debt in 2024 Q2 was -164.18 Billion KRW , up 70.38% from previous quarter.
LegoChem Biosciences, Inc. reported annual net debt of -105.71 Billion KRW in 2022, up 17.2% from previous year.
LegoChem Biosciences, Inc. reported annual net debt of -127.67 Billion KRW in 2021, down -390.19% from previous year.
LegoChem Biosciences, Inc. reported quarterly net debt of -554.23 Billion KRW for 2024 Q1, down -888.76% from previous quarter.
LegoChem Biosciences, Inc. reported quarterly net debt of -89.2 Billion KRW for 2023 Q1, up 15.62% from previous quarter.

Annual Net Debt Chart of LegoChem Biosciences, Inc. (2023 - 2016)

Historical Annual Net Debt of LegoChem Biosciences, Inc. (2023 - 2016)

Year	Net Debt	Net Debt Growth
2023	-56.05 Billion KRW	46.98%
2022	-105.71 Billion KRW	17.2%
2021	-127.67 Billion KRW	-390.19%
2020	-26.04 Billion KRW	59.75%
2019	-64.7 Billion KRW	-533.02%
2018	-10.22 Billion KRW	-321.66%
2017	4.61 Billion KRW	-47.72%
2016	8.81 Billion KRW	0.0%

Year	Net Debt	Net Debt Growth
2024 Q2	-164.18 Billion KRW	70.38%
2024 Q1	-554.23 Billion KRW	-888.76%
2023 Q1	-89.2 Billion KRW	15.62%
2023 Q4	-56.05 Billion KRW	22.15%
2023 Q3	-72 Billion KRW	11.29%
2023 Q2	-81.16 Billion KRW	9.02%
2023 FY	-56.05 Billion KRW	46.98%
2022 Q3	-120.04 Billion KRW	-12.03%
2022 Q4	-105.71 Billion KRW	11.94%
2022 Q2	-107.15 Billion KRW	13.83%
2022 Q1	-124.34 Billion KRW	2.6%
2021 Q3	-53.05 Billion KRW	0.0%
2021 Q4	-127.67 Billion KRW	-140.66%

Peer Net Debt Comparison of LegoChem Biosciences, Inc.

Name	Net Debt	Net Debt Difference
HLB Co., Ltd.	-46.18 Billion KRW	-21.372%
iNtRON Biotechnology, Inc.	-40.58 Billion KRW	-38.115%
BINEX Co., Ltd.	45.34 Billion KRW	223.609%
Bioneer Corporation	-3.9 Billion KRW	-1334.406%
Anterogen.Co.,Ltd.	8.35 Billion KRW	771.157%
MEDIPOST Co., Ltd.	14.81 Billion KRW	478.374%
CrystalGenomics, Inc.	8.99 Billion USD	723.378%
Helixmith Co., Ltd	-24.42 Billion KRW	-129.485%
Chabiotech Co.,Ltd.	388.94 Billion KRW	114.412%
Medy-Tox Inc.	49.58 Billion KRW	213.047%
Peptron, Inc.	4.86 Billion KRW	1251.321%
Amicogen, Inc.	125.26 Billion KRW	144.749%
Genexine, Inc.	61.39 Billion KRW	191.299%
HLB Therapeutics Co.,Ltd.	-13.68 Billion KRW	-309.545%
ALTEOGEN Inc.	53.56 Billion KRW	204.636%
PharmaResearch Co., Ltd.	-32.93 Billion KRW	-70.177%
SillaJen, Inc.	-13.89 Billion KRW	-303.507%
JETEMA, Co., Ltd.	84.27 Billion KRW	166.509%
OliX Pharmaceuticals,Inc	27.37 Billion KRW	304.763%
Genomictree Inc.	-43.43 Billion KRW	-29.051%
MedPacto, Inc.	-64 Billion KRW	12.417%
D&D Pharmatech	-7.5 Billion KRW	-646.604%
EASY BIO,Inc.	53.21 Billion KRW	205.343%
GI Innovation, Inc.	-4.82 Billion KRW	-1062.333%